Key result
Concomitant aortic valve stenosis in patients undergoing percutaneous coronary intervention was associated with a higher risk of all-cause mortality compared to patients without aortic stenosis.
Why the study?
CAD and aortic valve stenosis frequently coexist, but the prognostic impact of aortic stenosis stratified by peak aortic jet velocity in patients undergoing PCI required investigation.
Does concomitant aortic valve stenosis worsen short- and long-term outcomes in patients undergoing percutaneous coronary intervention?
Cohort (n=9,690)
Yes
Does concomitant aortic valve stenosis worsen short- and long-term outcomes in patients undergoing percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Concomitant aortic stenosis, as defined by peak aortic jet velocity, significantly increases the risk of short- and long-term mortality and major adverse cardiovascular events in patients undergoing percutaneous coronary intervention.
Background: Coronary artery disease (CAD) and aortic valve stenosis (AS) often coexist, with AS exacerbating myocardial ischemia and affecting prognosis. Aims: To investigate the prognostic impact of AS stratified by peak aortic jet velocity (AV-Vel) in patients undergoing PCI. Methods and results: We conducted retrospective multicenter observational study involving patients who underwent percutaneous coronary intervention (PCI) between April 2013 and March 2019. The patients were divided into non-AS group and AS group. The AS group was further categorized: 2.6 ≤ AV-Vel < 3.0 m/s, mild AS; 3.0 ≤ AV-Vel < 4.0 m/s, moderate AS; and AV-Vel ≥ 4.0 m/s, severe AS. The primary outcome was all-cause mortality, and the secondary outcome was major adverse cardiovascular events (MACE), defined as a composite of all-cause mortality, myocardial infarction, or stroke. Multivariable Cox proportional hazards analysis was performed over 5-year observation period, with landmark analyses conducted at 30 days after PCI and from day 31 after PCI to 5 years. In total, 9,690 patients were analyzed (AS group, n = 361). Over a median follow-up of 2.57 (IQR: 0.89-4.24) years, AS group exhibited higher rates of mortality (HR: 3.06; 95% CI: 2.41-3.90; p < 0.001) and MACE (HR: 2.45; 95%CI: 1.97-3.04; p < 0.001) compared with non-AS group. Subgroup analysis revealed that patients with moderate and severe AS had worse short-term mortality and MACE within 30 days after PCI than the non-AS group, while patients with mild to severe AS showed significantly worse long-term outcomes than the non-AS group. Conclusions: AV-Vel is independently associated with both short- and long-term outcomes in patients undergoing PCI.
No takes yet. Share an insight, caveat, or question.
Iwai et al. (2026) conducted a cohort in Coronary artery disease with and without aortic valve stenosis (n=9,690). Aortic valve stenosis (peak aortic jet velocity ≥ 2.6 m/s) vs. No aortic valve stenosis (peak aortic jet velocity < 2.6 m/s) was evaluated on All-cause mortality (HR 3.06, 95% CI 2.41-3.90, p=<0.001). Concomitant aortic valve stenosis in patients undergoing percutaneous coronary intervention was associated with a higher risk of all-cause mortality compared to patients without aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: